Last reviewed · How we verify

NCT06238037

Bone Mineral Density in Patients With Sarcoidosis

Completed Last updated 6 March 2025
What this trial tests

trial in Sarcoidosis in 144 participants. Completed in 30 April 2024.

Timeline
1 December 2019
Primary endpoint
30 April 2024
30 April 2024

Quick facts

Lead sponsorUniversity of Aarhus
StatusCompleted
Study typeOBSERVATIONAL
Enrollment144
Start date1 December 2019
Primary completion30 April 2024
Estimated completion30 April 2024
Sites1 location across Denmark

Conditions studied

Sponsor

University of Aarhus

Who can join

18 and older, any sex, with Sarcoidosis or Osteoporosis Risk. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess the frequency and risk factors of decreased bone mineral density (BMD) and vertebral fractures in Danish patients with sarcoidosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sarcoidosis

Currently open trials in the same condition.

Other University of Aarhus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06238037.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing